Method for the prevention and treatment of a type i hypersensitivity disorder
CA 2320104 A1 · Owner: Woloski, Barry Michael Ronald · Inventors: Woloski, Barry Michael Ronald
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Administration of Rh antibodies to an animal is effective for reducing the intensity, duration or frequency of asthmatic exacerbations and of other type-, I hypersensitivity disorders. Compositions thereof are claimed and so are their uses to prevent such disorders. Treatment with Rh antibodies in said mammal can also reduce the dosage of concomitant or other medications required by the animal for the control of this illness.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 9, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 9, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 9, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.